21 Şubat 2008 Perşembe

MEDCHANNEL Announces U.S. Data Supports DG-HAL and Mucopexy with the HTS™Hemorrhoid Treatment System to Treat Patients with Grades II to IV Hemorrhoid

BOSTON -- MEDCHANNEL, LLC reports that preliminary data presented at the recent SAGES conference by Dr. Matthew Albert supports the treatment of patients with grade II to IV hemorrhoids with Doppler-guided Hemorrhoid Artery Ligation (DG-HAL) and mucopexy. Dr. Matthew Albert, a board certified colorectal surgeon and member of the Department of Colorectal Surgery at Florida Hospital, Orlando, FL, presented preliminary results using DG-HAL and mucopexy on his first 48 patients.

Approximately 500,000 patients are medically treated for hemorrhoids in the United States every year, with approximately 20% undergoing surgery. Hemorrhoids and traditional treatments are often painful.

The HTS Hemorrhoid Treatment System is the only device of its kind currently approved and commercialized in the United States. The HTS system enables DG-HAL by using Doppler guidance and simple suturing techniques to reduce blood flow to the hemorrhoids, allowing them to shrink and recede. The system also enables mucopexy of prolapsed hemorrhoids (lifting of protruding hemorrhoids) again, with simple suturing techniques; tissue is not cut or removed and both procedures are performed in an area devoid of nerve endings. Thousands of procedures have been performed successfully worldwide with patients reporting significantly less pain.

Hiç yorum yok: